A review of published patient data from the United States, the United Kingdom, and Australia found that in ovarian cancer (12), the frequency of BRCA1 mutations in different countries ranged from 3.4% to 47%, and the frequency of BRCA2 mutations ranged from 1% to 12%. This evidence concerns the gene BRCA1 and ovarian cancer.